On November 6, the internationally renowned journal Nature Communications published the research results of Professor Chen Zhong’s team at ZCMU, titled “Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke”. The team has long been engaged in research on brain diseases. In recent years, the team has focused on developing new targets and strategies for treating chronic neurological diseases such as ischemic brain injury and epilepsy. Their research has accomplished fruitful results: Cell Reports, 2023; Signal Transduct. Tar., 2023a, b, c; Ann. Neurology, 2023; PNAS, 2023a,b; Cell Reports, 2022; Nat. Commun., 2022a,b; Ann. Neurology, 2021; Nat. Commun., 2021; Nat. Nanotech, 2020.

The first author of this study is Researcher Wu Di from ZCMU, with Zhou Jing, a teacher from ZCUM, and Researcher Zheng Yanrong as co-first authors, and Chen Zhong and Wu Di as co-corresponding authors.